author

 
 

Meta

Lisa Jarvis
Japan Times
COMMENTARY / World
May 24, 2023
Yet another bad week for abortion rights in America
Judges on the U.S. 5th Circuit appeared worryingly comfortable challenging the expertise of FDA scientists.
Japan Times
COMMENTARY / World
May 22, 2023
Xylazine spreads faster than U.S. officials can act
The U.S. needs better ways of tracking illicit xylazine, a sedative that’s especially dangerous when mixed with fentanyl.
Japan Times
COMMENTARY / World
May 19, 2023
Bats, cheetahs and hippos unlock mysteries of the human genome
The decade-long Zoonomia project shows that animals have a lot to teach us about our health, disease, and potentially new ideas for medicines.
Japan Times
COMMENTARY / World
May 17, 2023
A breakthrough on Alzheimer's is closer than ever
Promising data could open the door to insurance coverage for expensive new Alzheimer's drugs, bringing them closer to patients.
Japan Times
COMMENTARY / World
Apr 21, 2023
Cancer vaccine hunt makes progress, finally
A small cancer drug study shows promise in deploying mRNA technology against melanoma, but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
COMMENTARY / World
Apr 19, 2023
Abortion pill rulings to impact pharmaceutical innovation
Bringing new drugs to market is already expensive and time-consuming. Undercutting the FDA will only make it harder.
Japan Times
COMMENTARY / World
Apr 12, 2023
Schizophrenia drug may offer much-needed progress
Late-stage data on a treatment in development by Karuna Therapeutics for schizophrenia show promise on sharply reducing harsh side effects.
Japan Times
COMMENTARY / World
Mar 8, 2023
Obesity drugs for kids? Why new guidelines make sense
The American Academy of Pediatrics thinks drugs like Wegovy and Mounjaro could help teens with weight loss.
Japan Times
COMMENTARY / World
Feb 27, 2023
A refreshing gamble on Crispr delivery
Biotech startup Aera is trying to shake up the always-just-out-of-reach field of genetic medicine.
Japan Times
COMMENTARY / World
Feb 13, 2023
The U.S. needs five times as many child psychiatrists
American kids are struggling with mental anxiety and other issues and there are too few trained adults available to help them.
Japan Times
COMMENTARY / World
Jan 11, 2023
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
COMMENTARY / World
Dec 21, 2022
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
Japan Times
COMMENTARY / World
Dec 2, 2022
Amgen has a contender in the weight-loss drug wars
Amgen's obesity drug offers a new twist on proven methods to help people lose unwanted pounds.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY
Oct 24, 2022
New COVID-19 variants have arrived. How worried should you be?
Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.
Japan Times
COMMENTARY / World
Oct 12, 2022
Don’t cancel your colonoscopy just yet
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it's a lot more complicated.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
COMMENTARY / World
Sep 1, 2022
To fight monkeypox and other viruses, look harder in the sewers
Health authorities rely on a patchwork system for testing wastewater, often missing important information about virus outbreaks such as monkeypox.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'